2010-08-23
FDA grants Orphan Drug Status for to-BBB's lead product
2010-06-14
to-BBB receives positive opinion for Orphan Drug Designation
2010-05-31
i-Optics 2nd place in Dutch Innovation top 100
2010-05-20
to-BBB announces pilot study with Janssen Pharmaceutica
show more
TEAM
�
Dinko Valerio,
General Partner
Michiel de Haan,
General Partner
Patrick Krol,
Investment Partner
Kreske Nickelsen,
Investment Partner
Tim Knotnerus,
Analyst
Wolfgang Noeldeke,
Financial Officer
Claire Harrison,
Legal Counsel
